Haploidentical allogeneic stem cell transplantation with post-transplant cyclophosphamide and subsequent kidney transplant for patients with severe sickle cell disease with end-stage kidney disease (ESKD)

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Bone marrow transplantation (Basingstoke) 2023-07, Vol.58 (7), p.835-838
Hauptverfasser:	Gomez-Arteaga, Alexandra, Orfali, Nina, Pasciolla, Michelle, Baptiste, Ayanna, Guindine, Inna, Hsu, Jingmei, Lin, Jonathan, Mayer, Sebastian A., Phillips, Adrienne A., Shore, Tsiporah B., Simonson, Paul D., DiCarlo, Edward, Yoon, Sung, Muthukumar, Thangamani, van Besien, Koen
Format:	Artikel
Sprache:	eng
Schlagworte:	631/532/1542 692/699/1541 Allografts Anemia, Sickle Cell - therapy Cell Biology Correspondence Cyclophosphamide Cyclophosphamide - therapeutic use End-stage renal disease Graft vs Host Disease Hematology Hematopoietic Stem Cell Transplantation Humans Internal Medicine Kidney diseases Kidney Failure, Chronic - therapy Kidney Transplantation Medicine Medicine & Public Health Public Health Sickle cell disease Stem cell transplantation Stem Cells Transplantation Transplantation Conditioning
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!